Pernix Therapeutics (PTX) Reports Q3 Loss of $2.99/Share

November 10, 2016 4:04 PM EST
Get Alerts PTX Hot Sheet
Trade PTX Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Pernix Therapeutics (NASDAQ: PTX) reported Q3 EPS of ($2.99), versus ($1.76) reported last year. Revenue for the quarter came in at $41.5 million, versus $48.6 million reported last year.

For earnings history and earnings-related data on Pernix Therapeutics (PTX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment